US launches new trade probe into Germany's pharma pricing
The US has launched a Section 301 trade investigation into Germany’s pricing practices for pharmaceuticals, a move that is likely to increase tensions with Europe amid unsteady trading relations.The US has...To view the full article, register now.
Already a subscriber? Click here to view full article